Kairos Pharma | 8-K: Current report
Kairos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Murali Ramachandran
Kairos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Samuelson Doug
Kairos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Yu John S
Kairos Pharma | 8-K: Current report
Kairos Pharma | 10-Q: Q3 2024 Earnings Report
Kairos Pharma | 8-K: Current report
Kairos Pharma | 8-K: Current report
Kairos Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kairos Pharma | 8-K: Current report
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Officer Bhowmick Neil
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Director MAZANET ROSEMARY
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Officer Murali Ramachandran
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Director Keyoung Hansoo Michael
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Officer Samuelson Doug
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Officer Yu John S
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Director Bae Hyun W.
Kairos Pharma | 8-K: Current report
Kairos Pharma | 8-K: Current report
Kairos Pharma | 424B4: Prospectus
No Data